(Q46669947)

24 December 2017

title

Follistatin attenuates early liver fibrosis: effects on hepatic stellate cell activation and hepatocyte apoptosis (English)

1 reference

24 December 2017

author name string

Shane Patella

1

1 reference

24 December 2017

David J Phillips

2

1 reference

24 December 2017

Jorge Tchongue

3

1 reference

24 December 2017

David M de Kretser

4

1 reference

24 December 2017

William Sievert

5

1 reference

24 December 2017

publication date

25 August 2005

1 reference

24 December 2017

American Journal of Physiology - Gastrointestinal and Liver Physiology

published in

1 reference

24 December 2017

volume

290

1 reference

24 December 2017

issue

1

1 reference

24 December 2017

page(s)

G137-44

1 reference

24 December 2017

Apoptosis: the nexus of liver injury and fibrosis.

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00080.2005

Therapeutic potential of follistatin for colonic inflammation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00080.2005

Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00080.2005

Angiotensin II, TGF-beta and renal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00080.2005

Purification of rat hepatic stellate cells by side scatter-activated cell sorting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00080.2005

In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: a potential new therapy for hepatic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00080.2005

Roles of TGF-beta in hepatic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00080.2005

Induction of apoptosis in the murine liver with recombinant human activin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00080.2005

Transforming growth factor beta and activin tonically inhibit DNA synthesis in the rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00080.2005

Cell type-specific intervention of transforming growth factor beta/Smad signaling suppresses collagen gene expression and hepatic fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00080.2005

Histological grading and staging of chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00080.2005

Intravenous administration of follistatin: delivery to the liver and effect on liver regeneration after partial hepatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00080.2005

The role of activin and transforming growth factor-beta in the regulation of organ mass in the rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00080.2005

Characterization of serum activin-A and follistatin and their relation to virological and histological determinants in chronic viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00080.2005

Transforming growth factor-beta in human glomerular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00080.2005

Follistatin: a multifunctional regulatory protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00080.2005

Evidence for activin A and follistatin involvement in the systemic inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00080.2005

Blockade of type beta transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00080.2005

Activin induces cell death in hepatocytes in vivo and in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00080.2005

Hepatocyte-specific disruption of Bcl-xL leads to continuous hepatocyte apoptosis and liver fibrotic responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00080.2005

The dependence of transforming growth factor-beta-induced collagen production on autocrine factor activin A in hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00080.2005

Relaxin inhibits effective collagen deposition by cultured hepatic stellate cells and decreases rat liver fibrosis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00080.2005

Activin A: an autocrine inhibitor of initiation of DNA synthesis in rat hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00080.2005

21 January 2018

Identifiers

DOI

10.1152/AJPGI.00080.2005

1 reference

24 December 2017

PubMed ID

16123203

1 reference

24 December 2017